Maheshwary, N. (2016) “EFFICACY AND COST EFFECTIVENESS OF BIOSIMILAR PEGYLATED INTERFERON α2a 180 µg/RIBAVIRIN IN NON-CIRRHOTIC TREATMENT NAÏVE GENOTYPE 3 PATIENTS”, Pakistan Journal of Physiology, 12(1), pp. 26–28. Available at: https://pjp.pps.org.pk/index.php/PJP/article/view/420 (Accessed: 3 May 2024).